Cargando…

Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens

Extracellular vesicles are membraneous particles released by a variety of cells into the extracellular microenvironment. Retroviruses utilize the cellular vesiculation pathway for virus budding/assembly and the retrovirus Gag protein induces the spontaneous formation of microvesicles or virus-like p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurg, Reet, Reinsalu, Olavi, Jagur, Sergei, Õunap, Kadri, Võsa, Liisi, Kasvandik, Sergo, Padari, Kärt, Gildemann, Kiira, Ustav, Mart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941533/
https://www.ncbi.nlm.nih.gov/pubmed/27403717
http://dx.doi.org/10.1038/srep29425
_version_ 1782442312585969664
author Kurg, Reet
Reinsalu, Olavi
Jagur, Sergei
Õunap, Kadri
Võsa, Liisi
Kasvandik, Sergo
Padari, Kärt
Gildemann, Kiira
Ustav, Mart
author_facet Kurg, Reet
Reinsalu, Olavi
Jagur, Sergei
Õunap, Kadri
Võsa, Liisi
Kasvandik, Sergo
Padari, Kärt
Gildemann, Kiira
Ustav, Mart
author_sort Kurg, Reet
collection PubMed
description Extracellular vesicles are membraneous particles released by a variety of cells into the extracellular microenvironment. Retroviruses utilize the cellular vesiculation pathway for virus budding/assembly and the retrovirus Gag protein induces the spontaneous formation of microvesicles or virus-like particles (VLPs) when expressed in the mammalian cells. In this study, five different melanoma antigens, MAGEA4, MAGEA10, MART1, TRP1 and MCAM, were incorporated into the VLPs and their localization within the particles was determined. Our data show that the MAGEA4 and MAGEA10 proteins as well as MCAM are expressed on the surface of VLPs. The compartmentalization of exogenously expressed cancer antigens within the VLPs did not depend on the localization of the protein within the cell. Comparison of the protein content of VLPs by LC-MS/MS-based label-free quantitative proteomics showed that VLPs carrying different cancer antigens are very similar to each other, but differ to some extent from VLPs without recombinant antigen. We suggest that retrovirus Gag based virus-like particles carrying recombinant antigens have a potential to be used in cancer immunotherapy.
format Online
Article
Text
id pubmed-4941533
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49415332016-07-20 Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens Kurg, Reet Reinsalu, Olavi Jagur, Sergei Õunap, Kadri Võsa, Liisi Kasvandik, Sergo Padari, Kärt Gildemann, Kiira Ustav, Mart Sci Rep Article Extracellular vesicles are membraneous particles released by a variety of cells into the extracellular microenvironment. Retroviruses utilize the cellular vesiculation pathway for virus budding/assembly and the retrovirus Gag protein induces the spontaneous formation of microvesicles or virus-like particles (VLPs) when expressed in the mammalian cells. In this study, five different melanoma antigens, MAGEA4, MAGEA10, MART1, TRP1 and MCAM, were incorporated into the VLPs and their localization within the particles was determined. Our data show that the MAGEA4 and MAGEA10 proteins as well as MCAM are expressed on the surface of VLPs. The compartmentalization of exogenously expressed cancer antigens within the VLPs did not depend on the localization of the protein within the cell. Comparison of the protein content of VLPs by LC-MS/MS-based label-free quantitative proteomics showed that VLPs carrying different cancer antigens are very similar to each other, but differ to some extent from VLPs without recombinant antigen. We suggest that retrovirus Gag based virus-like particles carrying recombinant antigens have a potential to be used in cancer immunotherapy. Nature Publishing Group 2016-07-11 /pmc/articles/PMC4941533/ /pubmed/27403717 http://dx.doi.org/10.1038/srep29425 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Kurg, Reet
Reinsalu, Olavi
Jagur, Sergei
Õunap, Kadri
Võsa, Liisi
Kasvandik, Sergo
Padari, Kärt
Gildemann, Kiira
Ustav, Mart
Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens
title Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens
title_full Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens
title_fullStr Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens
title_full_unstemmed Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens
title_short Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens
title_sort biochemical and proteomic characterization of retrovirus gag based microparticles carrying melanoma antigens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941533/
https://www.ncbi.nlm.nih.gov/pubmed/27403717
http://dx.doi.org/10.1038/srep29425
work_keys_str_mv AT kurgreet biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens
AT reinsaluolavi biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens
AT jagursergei biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens
AT ounapkadri biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens
AT vosaliisi biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens
AT kasvandiksergo biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens
AT padarikart biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens
AT gildemannkiira biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens
AT ustavmart biochemicalandproteomiccharacterizationofretrovirusgagbasedmicroparticlescarryingmelanomaantigens